DAWN News and Press, Day One Biopharmaceuticals Inc. From 03/05/26

2026-03-05 14:41:06 ET The last time I spoke about Day One Biopharmaceuticals ( DAWN ), it was regarding a Seeking Alpha article entitled " Day One Biopharmaceuticals: Mersana Acquisition Ignites March Towards Unmet Need ." I noted that this company had completed its acquisition o...

2026-03-04 13:04:44 ET More on Day One Biopharmaceuticals Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript Day One Biopharmaceuticals, Inc. 2025 Q4 - Results - Earnings Ca...

2026-02-27 15:29:35 ET ... Read the full article on Seeking Alpha For further details see: Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead

2026-02-25 06:12:10 ET More on Day One Biopharmaceuticals Day One Biopharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Day One Biopharmaceuticals, Inc. (DAWN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Day One Pharmaceutic...

2026-02-25 06:11:30 ET Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript

2026-02-24 18:11:11 ET Image source: The Motley Fool. Tuesday, Feb. 24, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

OJEMDA™ 2025 momentum reflected by Q4 and full year net product revenues of $52.8 million and $155.4 million, respectively 2026 U.S. net product revenue projected at $225 - $250 million Expanded pipeline with January 2026 acquisition of Mersana Therapeutics; Emi-Le in Phase 1 tria...

Interface Inc. (TILE) is expected to report $0.4 for Q4 2025 Evolent Health Inc Class A (EVH) is expected to report $-0.03 for Q4 2025 MercadoLibre Inc. (MELI) is expected to report $11.77 for Q4 2025 Clean Energy Fuels Corp. (CLNE) is expected to report $-0.1 for Q4 2025 Kiniksa ...

Day One Biopharmaceuticals Inc. (DAWN) is expected to report $-0.17 for Q4 2025

2026-02-23 17:38:53 ET Day One Biopharmaceuticals, Inc. (DAWN) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.52%. The average open to low on the day of earnings was -5.68%. The avera...